- Home
- CGC vs CION Comparison
CGC vs CION Comparison
Compare CGC & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGC | CION |
|---|---|---|
| Founded | N/A | 2011 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.6M | 464.0M |
| IPO Year | 2023 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CGC | CION |
|---|---|---|
| Price | $1.19 | $8.51 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 2 | 1 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | ★ 10.9M | 393.1K |
| Earning Date | 05-09-2026 | 03-23-2026 |
| Dividend Yield | N/A | ★ 13.90% |
| EPS Growth | ★ 36.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,759,000.00 | N/A |
| Revenue This Year | $6.79 | N/A |
| Revenue Next Year | $7.34 | N/A |
| P/E Ratio | ★ N/A | $17.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $8.47 |
| 52 Week High | $2.38 | $12.71 |
Technical Indicators
Market Signals| Indicator | CGC | CION |
|---|---|---|
| Relative Strength Index (RSI) | 53.97 | 31.71 |
| Support Level | $1.02 | $8.47 |
| Resistance Level | $1.15 | $8.74 |
| Average True Range (ATR) | 0.06 | 0.22 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 80.95 | 7.10 |
Price Performance
Historical ComparisonAbout CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.